AKERO THERAPEUTICS INC (AKRO) Stock Balance Sheet
USA - NASDAQ:AKRO - US00973Y1082 - Common Stock
54.25 USD
+0.05 (+0.09%)
54.25 USD
0 (0%)
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 176.03M | 340.24M | 234.21M | 249.80M | 150.50M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 561.79M | 402.84M | 315.80M | 101.70M | 37.80M | |||
| Receivables | null | null | null | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 16.71M | 27.30M | 9.95M | 3.70M | 5.30M | |||
| Total Current Assets | 754.53M | 770.38M | 559.96M | 355.20M | 193.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 552.00K | 755.00K | 1.03M | 1.30M | 1.50M | |||
| Investments And Advances | 250.49M | 54.75M | 19.28M | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | null | 0 | 0 | 100.00K | 400.00K | |||
| Total Non-Current Assets | 251.04M | 55.51M | 20.31M | 1.40M | 1.90M | |||
| TOTAL ASSETS | 1.01B | 825.89M | 580.27M | 356.60M | 195.50M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 27.25M | 30.73M | 12.09M | 11.10M | 18.40M | |||
| Accounts Payable | 20.40M | 9.03M | 7.04M | 8.00M | 6.70M | |||
| Other Current Liabilities | null | null | null | null | null | |||
| Total Current Liabilities | 47.65M | 39.75M | 19.13M | 19.10M | 25.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 35.30M | 24.96M | 9.50M | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 289.00K | 723.00K | 873.00K | 1.40M | 1.30M | |||
| Total Non-Current Liabilities | 289.00K | 36.02M | 25.84M | 10.90M | 1.30M | |||
| TOTAL LIABILITIES | 47.94M | 75.77M | 44.97M | 30.00M | 26.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.05B | -826.16M | -574.10M | -422.30M | -310.30M | |||
| Additional Paid In Capital | 2.00B | 1.58B | 1.11B | 748.90M | 479.40M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 8.00K | 7.00K | 6.00K | 0 | 0 | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | 1.83M | 948.00K | 270.00K | 0 | 0 | |||
| Shares Outstanding | 80.15M | 72.38M | 55.75M | 46.90M | 34.90M | |||
| Tangible Book Value per Share | 11.9482 | 10.3631 | 9.6011 | 6.9638 | 4.8453 | |||
| Total Shareholders' Equity | 957.64M | 750.11M | 535.31M | 326.60M | 169.10M | |||
| TOTAL LIABILITIES AND EQUITY | 1.01B | 825.89M | 580.27M | 356.60M | 195.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.05 | 0.05 | 0.03 | N/A | |||
| Current Ratio | 15.83 | 19.38 | 29.27 | 18.60 | 7.71 | |||
| Return On Assets (ROA) | -29.12% | -30.52% | -26.15% | -31.42% | -51.55% | |||
| Return On Equity (ROE) | -30.58% | -33.60% | -28.35% | -34.30% | -59.60% | |||
All data in USD , ROIC based on taxRate of 0.21